@article{894da8d91a904e6d80021ca11dd40abd,
title = "Clinical instrument to retrospectively capture levels of EDSS",
abstract = "Background: The Expanded Disability Status Scale (EDSS), a common outcome measure in Multiple Sclerosis (MS), is obtained prospectively through a direct standardized evaluation. The objective of this study is to develop and validate an algorithm to derive EDSS scores from previous neurological clinical documentation. Methods: The algorithm utilizes data from the history, review of systems, and physical exam. EDSS scores formally obtained from research patients were compared to captured EDSS (c‐EDSS) scores. To test inter‐rater reliability, a second investigator captured scores from a subset of patients. Agreement between formal and c-EDSS scores was assessed using a weighted kappa. Clinical concordance was defined as a difference of one-step in EDSS (0.5) and functional system (1.0) scores. Results: Clinical documentation from 92 patients (EDSS range 0.0–8.5) was assessed. Substantial agreement between the c‐EDSS and formal EDSS (kappa 0.80; 95% CI 0.74–0.86) was observed. The mean difference between scores was 0.16. The clinical concordance was 78%. Near-perfect agreement was found between the two raters (kappa 0.89; 95% CI 0.84–0.95). The mean inter-rater difference in c-EDSS was 0.23. Conclusions: This algorithm reliably captures EDSS scores retrospectively with substantial correlation with formal EDSS and high inter‐rater agreement. This algorithm may have practical implications in clinic, MS research and clinical trials.",
keywords = "Algorithm, Chart review, Disability, Examination, Multiple sclerosis, Outcome measure",
author = "Ciotti, {John Robert} and Noah Sanders and Amber Salter and Berger, {Joseph R.} and Cross, {Anne Haney} and Salim Chahin",
note = "Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: John Ciotti has nothing to disclose. Noah Sanders has nothing to disclose. Amber Salter reports consulting fees for statistical reviews for Circulation: Cardiovascular Imaging. Joseph Berger reports grants and personal fees from Biogen, grants from TEVA, personal fees from Genentech/Roche, personal fees from Genzyme, personal fees from Millennium/Takeda, personal fees from Novartis, personal fees from Inhibikase, personal fees from ExcisionBio, personal fees from Roche, personal fees from Amgen, personal fees from Astra-Zeneca, personal fees from Alkermes, personal fees from Bayer. Anne Cross reports consulting honoraria from Biogen, Celgene, EMD Serono, Genentech/Roche, Novartis, and TG Therapeutics, and receives research support from Genentech and EMD Serono. Salim Chahin reports consulting and/or speaking honoraria from Biogen, Genentech, Sanofi Genzyme, Novartis, and Teva Neuroscience. Funding Information: The authors would like to acknowledge the principal investigator on the studies from which formal EDSS scores were obtained: Drs. Robert Naismith at Washington University in St. Louis and Clyde Markowitz and Dina Jacobs at the University of Pennsylvania. Publisher Copyright: {\textcopyright} 2019 Elsevier B.V.",
year = "2020",
month = apr,
doi = "10.1016/j.msard.2019.101884",
language = "English",
volume = "39",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
}